REGEND-003

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameREGEND-003
Drug Alias Name自体肾前体细胞REGEND003REGEND-003
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangxi Xianhe Medical Technology Co LtdRegend Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jirui Medical Technology Co LtdRegend Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A